The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this ...

MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...

The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...

The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

The San Diego-based biotech company Candid Therapeutics has launched with a huge $370 million with the aim to develop T-cell ...

Emmanuelle Cameau is strategic technology partnership leader at Cytiva. Read our interview to discover how losing her beloved ...

The European Commission has granted Orphan Drug Designation for Vivet Therapeutics’ gene therapy product VTX-806 for the ...